Trial Information
A Randomized Clinical Trial Examining the Efficacy of Treatment of Cutaneous Verruca Vulgaris in Adult Patients With Combined Liquid Nitrogen Cryotherapy and Topically Applied Cantharidin
Inclusion Criteria:
1. common warts on non-genital, non-facial skin
2. otherwise healthy
3. between 18-65 and able to give informed consent
4. capable of tolerating treatment
Exclusion Criteria:
1. Ill-health
2. Poor tolerance or sensitivity to treatments in study
3. <18 years old; >65 years old
4. verruca plana or condyloma acuminata
5. immunosuppression or immune dysfunction
6. significant peripheral vascular disease
7. significant sensitivity to cold
8. epidermodysplasia verruciformis
9. mosaiform warts or periungual warts
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
Percentage of common warts cleared
Outcome Description:
Percentage of treated warts cleared with treatment, as measured with dermatoscopic examination, after 12 weeks.
Outcome Time Frame:
12 weeks
Safety Issue:
No
Principal Investigator
Richard A Flygare, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
TUI University; North Idaho Dermatology
Authority:
United States: Institutional Review Board
Study ID:
NID-001
NCT ID:
NCT01084824
Start Date:
June 2007
Completion Date:
September 2008
Related Keywords:
- Verruca Vulgaris
- Warts
- Verruca vulgaris
- Liquid Nitrogen
- Cantharidin
- combination treatment
- Warts
Name | Location |
North Idaho Dermatology |
Coeur D'Alene, Idaho 83814 |